Abstract
Duchene muscular dystrophy (DMD) is an X-linked recessive disorder caused by mutations in the dystrophin gene. Patients with DMD present around 2–5 years of age with motor delays and non-motor delays in 1/3 of the patients. The most common motor delays are gait difficulties, toe walking, recurrent falls, inability to keep up with peers and proximal weakness. The non-motor complaints vary from autistic spectrum disorders to academic or behavioral difficulties. Physical examination reveals proximal muscle weakness, initially worse in the legs, pseudohypertrophy of the calves, lumbar lordosis, waddling gait, shortening of the Achilles tendon, hypotonia, hyporeflexia or areflexia and Gower’s sign. Laboratory investigations show elevated creatine kinase that is 10–20 times the upper limit of normal. Aldolase and other muscle enzymes such as aspartate transaminase (AST) and alanine transaminase (ALT) are also elevated. The majority of the mutations of the dystrophin gene are deletions of one or more exons, in approximately 60–65% of patients. Partial gene duplications, single nucleotide or splice variants are responsible for the other 35–40% of patients. Muscle biopsy with dystrophin protein analysis is useful to confirm the clinical diagnosis in rare “mutation-negative” cases. In those cases, a muscle biopsy reveals total absence of the dystrophin protein. Management involves steroids and multi-disciplinary care with neurology, cardiology, pulmonology and rehabilitation. New therapies that are being developed currently include gene transfer (micro-dystrophin), exon skipping, trans-splicing, genome editing, stop codon read-through and cell therapy.
Keywords
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Darras BT, Urion DK, Ghosh PS. Dystrophinopathies. 2000 Sep 5 [Updated 2018 Apr 26]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2019. www.ncbi.nlm.nih.gov/books/NBK1119. Accessed 31 May 2019.
Aartsma-Rus A, Van Deutekom JC, Fokkema IF, Van Ommen GJ, Den Dunnen JT. Entries in the Leiden Duchenne muscular dystrophy mutation database: an overview of mutation types and paradoxical cases that confirm the reading-frame rule. Muscle Nerve. 2006;34(2):135.
Romitti PA, Zhu Y, Puzhankara S, James KA, Nabukera SK, Zamba GK, Ciafaloni E, Cunniff C, Druschel CM, Mathews KD, Matthews DJ, Meaney FJ, Andrews JG, Conway KM, Fox DJ, Street N, Adams MM, Bolen J, MD STARnet. Prevalence of Duchenne and Becker muscular dystrophies in the United States. Pediatrics. 2015;135(3):513. Epub 2015 Feb 16
Birnkrant DJ, Bushby K, Bann CM, Apkon SD, Blackwell A, Brumbaugh D, Case LE, Clemens PR, Hadjiyannakis S, Pandya S, Street N, Tomezsko J, Wagner KR, Ward LM, Weber DR, DMD Care Considerations Working Group. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management. Lancet Neurol. 2018;17(3):251. Epub 2018 Feb 3
Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L, et al. Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care. Lancet Neurol. 2010;9(2):177–89.
Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L, et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol. 2010;9(1):77–93.
Yokota T, Maruyama R, Rodrigues M, Yokota T, Walker JM. An overview of recent advances and clinical applications of exon skipping and splice modulation for muscular dystrophy and various genetic disorders. Exon skipping and inclusion therapies: methods and protocols exon skipping and inclusion therapies. 09/01/2018.1828:31–55.
Shieh PB. Emerging strategies in the treatment of Duchenne muscular dystrophy. Neurotherapeutics. 2018;15(4):840–8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Castro, D.P., Cai, C., Jacob Paul, D. (2020). A 4-Year-Old Boy with Progressive Weakness, Difficulty Walking and Running, and Increased Falls. In: Zhou, L., Burns, D., Cai, C. (eds) A Case-Based Guide to Neuromuscular Pathology. Springer, Cham. https://doi.org/10.1007/978-3-030-25682-1_24
Download citation
DOI: https://doi.org/10.1007/978-3-030-25682-1_24
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-25681-4
Online ISBN: 978-3-030-25682-1
eBook Packages: MedicineMedicine (R0)